Landscapes / Companies
Zealand Pharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 5 in all
Trials
5 active
30 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
GLP analogue |
Approved in the EU | 18 Sep 2028Phase 3 trial completes | |||
| How it works | Copies GLP-1 or GLP-2 | ||||
| Next date | 18 Sep 2028 · Phase 3 trial completes | ||||
| Also tested for | Short Bowel Syndrome, Short Bowel Syndrome (SBS) | ||||
| Open drug page | |||||
— |
Phase 1 | 12 Apr 2027Phase 1 trial completes | |||
| Next date | 12 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Impaired Hepatic Function | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2027Phase 1 trial completes | |||
| Next date | Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Plaque Psoriasis | ||||
| Open drug page | |||||
About
- No active trial
- Dapiglutide, dasiglucagon
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021